Skip to content
Tuesday, 17 November 2026, Lagos
Economy

Federal Government, EU, and France Seal €10.2 Million Agreement to Boost Nigeria’s Pharmaceutical Manufacturing Capacity

By Lawal Odunmolorun Rofiat
Federal Government, EU, and France Seal €10.2 Million Agreement to Boost Nigeria’s Pharmaceutical Manufacturing Capacity

The Federal Government of Nigeria has entered into a €10.2 million partnership agreement with the European Union and the Government of France to strengthen the country’s pharmaceutical manufacturing industry. The pact, which was signed in Abuja, aims to enhance local drug production, improve regulatory standards, and reduce Nigeria’s dependence on imported medicines.

According to officials present at the signing ceremony, the initiative is designed to support Nigeria’s health sector reform agenda by promoting the production of high-quality, affordable medicines that meet international standards. The project will also provide technical assistance, capacity building, and technology transfer to local pharmaceutical firms to help them scale up operations and meet global best practices.

Representatives of the European Union and France described the collaboration as a strategic investment in Nigeria’s health security, emphasizing the need to strengthen local production in response to lessons learned from the COVID-19 pandemic and other global supply chain disruptions. They affirmed that the partnership would create jobs, foster innovation, and encourage sustainable industrial growth in the pharmaceutical sector.

The Minister of Health and Social Welfare commended the EU and France for their continued support, noting that the agreement aligns with President Bola Ahmed Tinubu’s Renewed Hope Agenda, which prioritizes industrial growth and public health advancement. He assured that the government is committed to creating a favorable policy environment that will enable the pharmaceutical sector to thrive and compete internationally.

Stakeholders in the industry have welcomed the development, describing it as a major step toward achieving self-sufficiency in drug production. They expressed optimism that the partnership would not only boost local manufacturing capacity but also ensure the availability of safe and effective medicines for millions of Nigerians.

Related stories

Nigeria’s Electric Vehicle Market Poised for Strong Growth in 2026

Nigeria’s electric vehicle market is projected to record significant expansion in 2026, driven by rising fuel costs, increasing environmental awareness and gradual improvements in supporting infrastructure. Industry watchers say the combination of economic pressure and policy interest is beginning…

Dangote Refinery Moves to Cushion Local Fuel Prices from Global Oil Swings

The Dangote Petroleum Refinery has reiterated its commitment to maintaining relative stability in domestic fuel prices despite ongoing fluctuations in the global crude oil market. Industry sources say the refinery’s strategy is anchored on large-scale local refining, reduced dependence on imported…

VAT to Apply on Mobile Transfers, USSD Payments from January 19

Nigerians will begin paying Value Added Tax (VAT) on mobile bank transfers and USSD-based payments from January 19, 2026, following a new directive backed by the Federal Government. The development was communicated to customers by digital financial services provider, Moniepoint, which issued a…